FDA Approves Clesrovimab-cfor for Prevention of RSV in Infants
Drug Topics
JUNE 10, 2025
RSV disease is the leading cause of infant hospitalization in the US and can lead to serious respiratory conditions like bronchiolitis and pneumonia,” Octavio Ramilo, an investigator on the CLEVER and SMART trials., said in a release.
430 
Let's personalize your content